Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-29 @ 2:31 PM
Study NCT ID:
NCT06205706
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-19
First Post:
2023-12-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
Sponsor:
BioInvent International AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-04
Start Date Type:
ACTUAL
Primary Completion Date:
2027-07-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-18
First Submit QC Date:
None
Study First Post Date:
2024-01-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-15
Last Update Post Date:
2025-09-19
Last Update Post Date Type:
ESTIMATED